A first: Drug lowers heart risks by curbing inflammation

People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more study because the heart experiment wasn’t intended to test that.

Trump tells Mattis to indefinitely ban transgender recruits

The Obama administration in June 2016 had changed longstanding policy, declaring that troops could serve openly as transgender individuals. And it set a July 2017 deadline for determining whether transgender people could be allowed to enter the military. Defense Secretary Jim Mattis delayed that to Jan. 1, 2018, and Trump has now instructed Mattis to extend it indefinitely.